Epigenetic mechanisms regulate sex differences in cardiac reparative functions of bone marrow progenitor cells
Charan Thej,Rajika Roy,Zhongjian Cheng,Venkata Naga Srikanth Garikipati,May M. Truongcao,Darukeshwara Joladarashi,Vandana Mallaredy,Maria Cimini,Carolina Gonzalez,Ajit Magadum,Jayashri Ghosh,Cindy Benedict,Walter J. Koch,Raj Kishore
DOI: https://doi.org/10.1038/s41536-024-00362-2
IF: 14.404
2024-04-29
npj Regenerative Medicine
Abstract:Abstract Historically, a lower incidence of cardiovascular diseases (CVD) and related deaths in women as compared with men of the same age has been attributed to female sex hormones, particularly estrogen and its receptors. Autologous bone marrow stem cell (BMSC) clinical trials for cardiac cell therapy overwhelmingly included male patients. However, meta-analysis data from these trials suggest a better functional outcome in postmenopausal women as compared with aged-matched men. Mechanisms governing sex-specific cardiac reparative activity in BMSCs, with and without the influence of sex hormones, remain unexplored. To discover these mechanisms, Male (M), female (F), and ovariectomized female (OVX) mice-derived EPCs were subjected to a series of molecular and epigenetic analyses followed by in vivo functional assessments of cardiac repair. F-EPCs and OVX EPCs show a lower inflammatory profile and promote enhanced cardiac reparative activity after intra-cardiac injections in a male mouse model of myocardial infarction (MI). Epigenetic sequencing revealed a marked difference in the occupancy of the gene repressive H3K9me3 mark, particularly at transcription start sites of key angiogenic and proinflammatory genes in M-EPCs compared with F-EPCs and OVX-EPCs. Our study unveiled that functional sex differences in EPCs are, in part, mediated by differential epigenetic regulation of the proinflammatory and anti-angiogenic gene CCL3, orchestrated by the control of H3K9me3 by histone methyltransferase, G9a/Ehmt2. Our research highlights the importance of considering the sex of donor cells for progenitor-based tissue repair.
cell & tissue engineering,engineering, biomedical